A Novel Mutation Glyl672→Arg in Type 2A and a Homozygous Mutation in Type 2B von Willebrand Disease

Summary

Genetic materials from 16 unrelated Japanese patients with von Willebrand disease (vWD) were analyzed for mutations. Exon 28 of the von Willebrand factor (vWF) gene, where point mutations have been found most frequent, was screened by various restriction-enzyme analyses. Six patients were observed to have abnormal restriction patterns. By sequence analyses of the polymerase chain-reaction products, we identified a homozygous R1308C missense mutation in a patient with type 2B vWD; R1597W, R1597Q, G1609R and G1672R missense mutations in five patients with type 2A; and a G1659ter nonsense mutation in a patient with type 3 vWD. The G1672R was a novel missense mutation of the carboxyl-terminal end of the A2 domain. In addition, we detected an A/C polymorphism at nucleotide 4915 with HaeIII. There was no particular linkage disequilibrium of the A/C polymorphism, either with the G/A polymorphism at nucleotide 4391 detected with Hphl or with the C/T at 4891 detected with BstEll.

• References

• 1 Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-2764
• 2 Nachman R, Levine R, Jaffe EA. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 1977; 60: 914-921
• 3 Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor: studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand’s disease. J Clin Invest 1977; 60: 390-404
• 4 Ruggeri ZM, Zimmermann TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904
• 5 Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-19527
• 6 Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM, Sadler JE. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991; 30: 253-269
• 7 Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-525
• 8 Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. Thromb Haemost 1993; 69: 177-184
• 9 Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990; 87: 6306-6310
• 10 Marti T, Rösselet SJ, Titani K, Walsh KA. Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 1987; 26: 8099-8109
• 11 Bonthron D, Orr EC, Mitsock LM, Ginsburg D, Handin RI, Orkin SH. Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res 1986; 14: 7125-7127
• 12 Bonthron D, Orkin SH. The human von Willebrand factor gene. Structure of the 5’ region. Eur J Biochem 1988; 171: 51-57
• 13 Sadler JE, Ginsburg D. A database of polymorphisms in the von Willebrand factor gene and pseudogene. Thromb Haemost 1993; 69: 185-191
• 14 Ginsburg D, Konkle BA, Gill JC, Montgomery RR, Bockenstedt PL, Johnson TA, Yang AY. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. Pro Natl Acad Sci USA 1989; 86: 3723-3727
• 15 Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 1992; 267: 4424-4430
• 16 Sugiura I, Matsushita T, Tanimoto M, Takahashi I, Yamazaki T, Yamamoto K, Takamatsu J, Kamiya T, Saito H. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease. Thromb Haemost 1992; 67: 612-617
• 17 Inbal A, Seligsohn U, Kombrot N, Brenner B, Harrison P, Randi A, Rabi-nowitz I, Sadler JE. Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families. Thromb Haemost 1992; 67: 618-622
• 18 Winter PC, Mayne EE. An alternative strategy for identification of type IIA vWD mutations. Br J Haematol 1993; 84: 521-523
• 19 Lavergne J-M, De Paillette L, Bahnak BR, Ribba A-S, Fressinaud E, Meyer D, Pietu G. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX. Br J Haematol 1992; 82: 66-72
• 20 Inbal A, Englender T, Kombrot N, Randi AM, Castaman G, Mannucci PM, Sadler JE. Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method. Blood 1993; 82: 830-836
• 21 Donnér M, Kristoffersson A-C, Bemtorp E, Scheibel E, Thorsen S, Dahl-bäck B, Nilsson IM, Holmberg L. Two new candidate mutations in type IIA von Willebrand’s disease (Arg⁸³⁴→GLY, GLY⁸⁴⁶→ARG) and one polymorphism (TYR⁸²¹→CYS) in the A2 region of the von Willebrand factor. Eur J Haematol 1993; 51: 38-44
• 22 Sadler JE, Shelton-Inloes BB, Sorace JM, Harlan JM, Titani K, Davie EW. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 1985; 82: 6394-6398
• 23 Shelton-Inloes BB, Titani K, Sadler JE. cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 1986; 25: 3164-3171
• 24 Randi AM, Rabinowitz I, Mancuso DJ, Mannucci PM, Sadler JE. Molecular basis of von Willebrand disease type IIB: candidate mutations cluster in one disulfide loop between proposed platelet glcoprotein lb binding sequences. J Clin Invest 1991; 87: 1220-1226
• 25 Cooney KA, Nichols WC, Bmck ME, Bahou WF, Shapiro AD, Bowie EJW, Gralnick HR, Ginsburg D. The molecular defect in type IIB von Willebrand disease: identification of four potential missence mutations within the putative gplb binding domain. J Clin Invest 1991; 87: 1227-1233
• 26 Donnér M, Andersson A-M, Kristoffersson A-C, Nilsson IM, Dahlbäck B, Holmberg L. An Arg⁵⁴⁵→Cys⁵⁴⁵ substitution mutation of the von Willebrand factor in type IIB von Willebrand’s disease. Eur J Haematol 1991; 47: 342-345
• 27 Zhang ZP, Falk G, Blombéck M, Egberg N, Anvret M. Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III. Hum Mol Genet 1992; 1: 61-62
• 28 Inbal A, Kombrot N, Harrison P, Randi AM, Sadler JE. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein lb binding-studies with recombinant von Willebrand factor. Thromb Haemost 1993; 70: 1058-1062